XML 23 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Income/(Loss) and Comprehensive Income/(Loss) - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Apr. 30, 2021
Apr. 30, 2020
Apr. 30, 2019
Income Statement [Abstract]      
Net sales $ 1,059,195 $ 529,618 $ 481,336
Cost of sales 610,212 363,929 335,052
Gross profit 448,983 165,689 146,284
Operating expenses:      
Research and development 7,480 7,364 8,008
Selling, marketing, and distribution 42,603 41,987 27,693
General and administrative 79,268 66,033 67,066
Total operating expenses 129,351 115,384 102,767
Operating income from continuing operations 319,632 50,305 43,517
Other income/(expense), net:      
Other income/(expense), net 2,252 495 477
Interest expense, net (3,919) (11,625) (9,790)
Total other income/(expense), net (1,667) (11,130) (9,313)
Income from continuing operations before income taxes 317,965 39,175 34,204
Income tax expense 74,394 11,522 9,284
Income from continuing operations 243,571 27,653 24,920
Discontinued operations:      
Income/(loss) from discontinued operations, net of tax 8,478 (88,883) (6,510)
Net income/(loss) 252,049 (61,230) 18,410
Comprehensive income/(loss):      
Other comprehensive loss, net of tax   (547) (1,069)
Comprehensive income/(loss): $ 252,049 $ (61,777) $ 17,341
Net income/(loss) per share:      
Basic - continuing operations $ 4.46 $ 0.50 $ 0.46
Basic - net income/(loss) 4.62 (1.11) 0.34
Diluted - continuing operations 4.40 0.50 0.45
Diluted - net income/(loss) $ 4.55 $ (1.10) $ 0.33
Weighted average number of common shares outstanding:      
Basic 54,613 54,983 54,483
Diluted 55,352 55,665 55,216